C12N15/1137 - page 10 - CPC Classification Index

#2701

20130065946

2013-03-14

Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155

#2702

20130065945

2013-03-14

NLK as a marker for diagnosis of liver cancer and as a therapeutic agent thereof

#2703

20130065943

2013-03-14

Compositions and methods for inhibiting expression of CD45 gene

#2704

20130065939

2013-03-14

Compositions and methods for silencing genes expressed in cancer

#2705

20130065298

2013-03-14

SiRNA-mediated gene silencing

#2706

20130059305

2013-03-07

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#2707

20130059304

2013-03-07

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#2708

20130059298

2013-03-07

Composition and Method for Treatment of Tumors

#2709

20130058944

2013-03-07

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

#2710

20130053572

2013-02-28

Cationic lipids for oligonucleotide delivery

#2711

20130052201

2013-02-28

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

#2712

20130047297

2013-02-21

POLYNUCLEOTIDE MOLECULES FOR GENE REGULATION IN PLANTS

#2713

20130045520

2013-02-21

Double-stranded oligonucleotides

#2714

20130045506

2013-02-21

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#2715

20130041014

2013-02-14

Isoform of bruton's tyrosine kinase (BTK) protein

#2716

20130041013

2013-02-14

ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN

#2717

20130041012

2013-02-14

NEW ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN

#2718

20130041010

2013-02-14

COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA CONTAINING MODIFIED NUCLEOTIDES

#2719

20130039854

2013-02-14

Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer

#2720

20130035371

2013-02-07

Lipid formulated dsRNA targeting the PCSK9 gene

#2721

20130035369

2013-02-07

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2722

20130034543

2013-02-07

MODULATING XRN1

#2723

20130028886

2013-01-31

PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TUMOR INITIATING CELLS

#2724

20130028885

2013-01-31

Methods to predict and prevent resistance to taxoid compounds

#2725

20130023529

2013-01-24

Methods involving aldose reductase inhibitors

#2726

20130022667

2013-01-24

Fidgetin-like 2 as a target to enhance wound healing

#2727

20130022617

2013-01-24

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#2728

20130018087

2013-01-17

miRNA compounds for treatment of prostate carcinoma

#2729

20130018086

2013-01-17

SIRNAS TARGETING EXON 10 OF PYRUVATE KINASE M2

#2730

20130018083

2013-01-17

Use of siRNA targetting SIPA1L1 for the reduction of adipogenesis

#2731

20130017252

2013-01-17

Method for selectively inhibiting the activity of ACAT1 in the treatment of alzheimer's disease

#2732

20130017207

2013-01-17

Chemotherapeutic methods and compositions

#2733

20130012572

2013-01-10

Compositions and methods for inhibiting expression of GSK-3 genes

#2734

20130011497

2013-01-10

Protein arginine N-methyltransferase-5 method of cancer treatment

#2735

20120329858

2012-12-27

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

#2736

20120329721

2012-12-27

MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS

#2737

20120329101

2012-12-27

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

#2738

20120328646

2012-12-27

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

#2739

20120328609

2012-12-27

Modulation of Axon Degeneration

#2740

20120322075

2012-12-20

Lung Tumor Markers and Methods of Use Thereof

#2741

20120321639

2012-12-20

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

#2742

20120321608

2012-12-20

DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, OAS1

#2743

20120321575

2012-12-20

Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis

#2744

20120316223

2012-12-13

Modulation of pre-mRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease

#2745

20120309814

2012-12-06

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1

#2746

20120309813

2012-12-06

Delivery of dsRNA to arthropods

#2747

20120309059

2012-12-06

Polypeptides having endoglucanase activity and polynucleotides encoding same

#2748

20120302623

2012-11-29

Activation and transfer cascade for ubiquitin

#2749

20120301944

2012-11-29

BGL6 beta-glucosidase and nucleic acids encoding the same

#2750

20120301537

2012-11-29

LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF

#2751

20120301475

2012-11-29

Heparanase splice variant

#2752

20120295959

2012-11-22

Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1

#2753

20120294932

2012-11-22

Prostate carcinogenesis predictor

#2754

20120294872

2012-11-22

Method of predicting and reducing risk of metastasis of breast cancer to lung

#2755

20120291155

2012-11-15

Means for inducing apoximis in cultivated plants having sexual reproduction and use thereof for the production of completely or partially apomictic plants

#2756

20120289580

2012-11-15

Antisense modulation of PTP1B expression

#2757

20120283317

2012-11-08

Methods and compositions for regulating RNA import into mitochondria

#2758

20120283194

2012-11-08

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

#2759

20120282674

2012-11-08

METHOD FOR THE PREPARATION OF AN INFLUENZA VIRUS

#2760

20120282322

2012-11-08

Cochleate compositions directed against expression of proteins

#2761

20120277292

2012-11-01

Antisense oligonucleotides against cPLA, compositions and uses thereof

#2762

20120277289

2012-11-01

ACTIVITY GENERATING DELIVERY MOLECULES

#2763

20120272410

2012-10-25

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

#2764

20120264813

2012-10-18

SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

#2765

20120263738

2012-10-18

MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES

#2766

20120259150

2012-10-11

Compositions and Methods of Sphingosine Kinase Inhibitors In Radiation Therapy of Various Cancers

#2767

20120258646

2012-10-11

Compositions for controlling mites in bees

#2768

20120258116

2012-10-11

Method for inducing cancer cell apoptosis or inhibiting the cancer cell migration

#2769

20120253027

2012-10-04

Detection of mutations in a gene associated with resistance to viral infection, OAS1

#2770

20120252874

2012-10-04

Methods for delivery of siRNA to the spinal cord and therapies arising therefrom

#2771

20120252869

2012-10-04

TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)

#2772

20120252868

2012-10-04

Means and methods for the treatment of hearing loss and phantom hearing

#2773

20120252737

2012-10-04

Methods for Diagnosing and Treating Cancer

#2774

20120252023

2012-10-04

Materials and methods useful for affecting tumor cell growth, migration and invasion

#2775

20120251560

2012-10-04

Conjugated lipomers and uses thereof

#2776

20120251544

2012-10-04

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

#2777

20120251499

2012-10-04

Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single CpG site in TTP promoter and treatment of cancers by regulating its epigenetic status

#2778

20120244207

2012-09-27

Methods for increasing efficacy of lipid formulated siRNA

#2779

20120244120

2012-09-27

INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION

#2780

20120237589

2012-09-20

AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS

#2781

20120232125

2012-09-13

MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 1 EXPRESSION

#2782

20120225928

2012-09-06

Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes

#2783

20120225434

2012-09-06

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

#2784

20120225082

2012-09-06

ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis

#2785

20120225077

2012-09-06

Molecules of the card-related protein family and uses thereof

#2786

20120220496

2012-08-30

siRNA targeting catenin, Beat-1 (CTNNB1)

#2787

20120214865

2012-08-23

Methods for slowing familial ALS disease progression

#2788

20120214862

2012-08-23

MODULATION OF FACTOR 7 EXPRESSION

#2789

20120214736

2012-08-23

COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS

#2790

20120213797

2012-08-23

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

#2791

20120208864

2012-08-16

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCGR

#2792

20120208860

2012-08-16

Compositions and methods for inhibiting expression of factor VII gene

#2793

20120202875

2012-08-09

Method Of Treatment

#2794

20120196920

2012-08-02

ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES

#2795

20120185971

2012-07-19

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#2796

20120184031

2012-07-19

ANTISENSE INHIBITION VIA RNASE H-INDEPENDENT REDUCTION IN MRNA

#2797

20120183602

2012-07-19

Lipid formulation

#2798

20120183581

2012-07-19

Lipid formulations for nucleic acid delivery

#2799

20120178796

2012-07-12

SPLICE VARIANTS

#2800

20120178794

2012-07-12

RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders

#2801

20120174259

2012-07-05

Nucleic acid molecules that target the vacuolar atpase C subunit and confer resistance to coleopteran pests

#2802

20120171220

2012-07-05

Further use of protein kinase N beta

#2803

20120165395

2012-06-28

Bruton's tyrosine kinase as anti-cancer drug target

#2804

20120165391

2012-06-28

Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis

#2805

20120165390

2012-06-28

Compositions and Methods for Therapy and Diagnosis of Cancer

#2806

20120159657

2012-06-21

Compositions and methods for inhibiting expression of RRM2 genes

#2807

20120157507

2012-06-21

USP47 inhibitors and methods to induce apoptosis

#2808

20120156180

2012-06-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES

#2809

20120151621

2012-06-14

GENES FOR MICROSOMAL DELTA-12 FATTY ACID DESATURASES AND HYDROXYLASES FROM PLANTS

#2810

20120149760

2012-06-14

Disabling autophagy as a treatment for lysosomal storage diseases

#2811

20120149755

2012-06-14

ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION

#2812

20120144511

2012-06-07

MUTEINS OF THE PYRROLINE-5-CARBOXYLATE REDUCTASE 1

#2813

20120144504

2012-06-07

CASPASE-8 AND SKIN DISEASE

#2814

20120142758

2012-06-07

Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene

#2815

20120142608

2012-06-07

RCA LOCUS ANALYSIS TO ASSESS SUSCEPTIBILITY TO AMD AND MPGNII

#2816

20120141590

2012-06-07

Technology for the Preparation of Microparticles

#2817

20120141461

2012-06-07

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING FIBROTIC DISORDERS

#2818

20120136145

2012-05-31

Compositions and Methods for Inhibiting Expression of Eg5 Gene

#2819

20120136144

2012-05-31

SiRNA targeting catenin, beta-1 (CTNNB1)

#2820

20120136073

2012-05-31

Amine-Containing Transfection Reagents and methods for making and using same

#2821

20120136044

2012-05-31

Compositions And Methods Of Inhibiting NADPH Oxidase Expression

#2822

20120135892

2012-05-31

siRNA targeting spleen tyrosine kinase

#2823

20120129918

2012-05-24

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

#2824

20120129913

2012-05-24

dsRNA for treating viral infection

#2825

20120129788

2012-05-24

Phosphodiesterase 4D7 as marker for malignant, hormone-sensitive prostate cancer

#2826

20120129782

2012-05-24

Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders

#2827

20120128760

2012-05-24

Lipid compositions

#2828

20120128756

2012-05-24

Skin permeating and cell entering (SPACE) peptides and methods of use thereof

#2829

20120128679

2012-05-24

Human antibodies to the human glucagon receptor and methods of use thereof

#2830

20120128677

2012-05-24

Pancreatic cancer targets and uses thereof

#2831

20120122958

2012-05-17

Transcriptional repression leading to Parkinson's disease

#2832

20120122954

2012-05-17

Antisense oligomers targeting PCSK9

#2833

20120122217

2012-05-17

METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS

#2834

20120121697

2012-05-17

Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease

#2835

20120121559

2012-05-17

Treatment and prevention of pathological conditions using iduna related techniques and compositions

#2836

20120121515

2012-05-17

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

#2837

20120115926

2012-05-10

ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

#2838

20120115923

2012-05-10

Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment

#2839

20120108648

2012-05-03

Mitochondrial function-improving agent

#2840

20120107897

2012-05-03

DOUBLE-STRANDED OLIGONUCLEOTIDES

#2841

20120107297

2012-05-03

Method for therapeutic angiogenesis

#2842

20120100587

2012-04-26

BGL7 beta-glucosidase and nucleic acids encoding the same

#2843

20120100144

2012-04-26

Biomarker and Treatment for Cancer

#2844

20120095082

2012-04-19

Use of interfering rna for treating an hiv infection

#2845

20120095081

2012-04-19

Treatment of paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1

#2846

20120095074

2012-04-19

Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes

#2847

20120093916

2012-04-19

Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA

#2848

20120093913

2012-04-19

Inhibition of SYK kinase expression

#2849

20120093818

2012-04-19

Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)

#2850

20120093773

2012-04-19

Compositions for bacterial mediated gene silencing and methods of using same

#2851

20120077865

2012-03-29

Methods for treating hypercholesterolemia

#2852

20120077862

2012-03-29

Antisense modulation of PTP1B expression

#2853

20120076828

2012-03-29

Kanamycin antisense nucleic acid for the treatment of cancer

#2854

20120076781

2012-03-29

METHODS OF TREATING CANCERS WITH HER3 ANTISENSE OLIGONUCLEOTIDES

#2855

20120076735

2012-03-29

Nanoparticles for Extravascular Administration

#2856

20120071641

2012-03-22

Nucleic acid chemical modifications

#2857

20120071628

2012-03-22

TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE

#2858

20120071540

2012-03-22

Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer

#2859

20120071417

2012-03-22

Methods of inhibiting cancer cell growth with HDAC inhibitors and methods of screening for HDAC10 inhibitors

#2860

20120065148

2012-03-15

Phosphodiesterase 4D7 as prostate cancer marker

#2861

20120065100

2012-03-15

Phosphodiesterase 9A as prostate cancer marker

#2862

20120059046

2012-03-08

Inhibition of MAP4K4 through RNAI

#2863

20120059041

2012-03-08

Methods for Extending Lifespan in Subject

#2864

20120058144

2012-03-08

Lipids and compositions for the delivery of therapeutics

#2865

20120053230

2012-03-01

Treatment of neurological disorders by dsRNA administration

#2866

20120052487

2012-03-01

METHODS AND COMPOSITIONS FOR SELECTING SIRNA OF IMPROVED FUNCTIONALITY

#2867

20120046344

2012-02-23

Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1

#2868

20120046339

2012-02-23

gene from the potato cyst nematode

#2869

20120045811

2012-02-23

EGVII endoglucanase and nucleic acids encoding the same

#2870

20120045459

2012-02-23

Methods for Treating Autophagy-Related Disorders

#2871

20120041054

2012-02-16

Compositions and methods for the treatment of sepsis and other disorders involving phospholipase Ainduction

#2872

20120041053

2012-02-16

Delivery of dsRNA to arthropods

#2873

20120040459

2012-02-16

Reduced size self-delivering RNAi compounds

#2874

20120035244

2012-02-09

PARP1 TARGETED THERAPY

#2875

20120035242

2012-02-09

PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY OR DIABETES

#2876

20120034167

2012-02-09

Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer

#2877

20120029050

2012-02-02

Compositions and their uses directed to diacylglycerol acyltransferase 1

#2878

20120029049

2012-02-02

Antisense modulation of superoxide dismutase 1, soluble expression

#2879

20120028312

2012-02-02

METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE

#2880

20120028260

2012-02-02

RAD9 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC TOOL FOR PROSTATE CANCER

#2881

20120027766

2012-02-02

Methods and means for treatment of osteoarthritis

#2882

20120027765

2012-02-02

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

#2883

20120023626

2012-01-26

Polypeptides having endoglucanase activity and polynucleotides encoding same

#2884

20120020976

2012-01-26

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

#2885

20120020975

2012-01-26

Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

#2886

20120020953

2012-01-26

Diagnosis and treatment of cancer

#2887

20120016012

2012-01-19

RNAi molecule targeting thymidylate synthase and application thereof

#2888

20120016009

2012-01-19

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

#2889

20120015001

2012-01-19

Methods of treating thyroid eye disease

#2890

20120014964

2012-01-19

ALPHA SYNUCLEIN TOXICITY

#2891

20120014911

2012-01-19

Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor

#2892

20120010272

2012-01-12

RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

#2893

20120009193

2012-01-12

Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same

#2894

20120005765

2012-01-05

ANIMAL MODEL FOR PARKINSON'S DISEASE

#2895

20120004283

2012-01-05

ShRNA gene therapy for treatment of ischemic heart disease

#2896

20120004276

2012-01-05

RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF EXPRESSION OF MITOCHONDRIAL GLYCEROL-3 PHOSPHATE ACYLTRANSFERASE 1 (MTGPAT1)

#2897

20120003219

2012-01-05

Compositions and Methods to Treat Bone Related Disorders

#2898

20120003209

2012-01-05

Methods used in identifying glioblastoma

#2899

20120003156

2012-01-05

METHODS FOR TREATING NEOPLASIA BY INHIBITING LACTATE DEHYDROGENASE AND/OR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE

#2900

20110319474

2011-12-29

siRNA targeting cyclin-dependent kinase 4 (CDK4)

#2901

20110319471

2011-12-29

LNA ANTAGONISTS TARGETING THE ANDROGEN RECEPTOR

#2902

20110319317

2011-12-29

TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT1

#2903

20110318832

2011-12-29

Human telomerase catalytic subunit

#2904

20110318361

2011-12-29

Anticancer drug comprising inhibitor of TMPRSS4

#2905

20110313027

2011-12-22

METHODS AND SUBSTANCES FOR STIMULATING MUSCLE REGENERATION

#2906

20110313024

2011-12-22

RNA INTERFERENCE MEDIATED INHIBITION OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

#2907

20110313019

2011-12-22

Oligomeric compounds and methods

#2908

20110311523

2011-12-22

Platelet derived growth factor receptor supports cytomegalovirus infectivity

#2909

20110306655

2011-12-15

METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION

#2910

20110305675

2011-12-15

Methods for expansion of hematopoietic stem and progenitor cells

#2911

20110301242

2011-12-08

Inhibitors of cathepsin S for prevention or treatment of obesity-associated disorders

#2912

20110296556

2011-12-01

Method for controlling herbicide-resistant plants

#2913

20110294870

2011-12-01

TREATMENT OF TUMOR SUPPRESSOR GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO THE GENE

#2914

20110294213

2011-12-01

2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use

#2915

20110293703

2011-12-01

Aminoalcohol lipidoids and uses thereof

#2916

20110293628

2011-12-01

Pain treatment using ERK2 inhibitors

#2917

20110288157

2011-11-24

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

#2918

20110288156

2011-11-24

Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis

#2919

20110288155

2011-11-24

SIRNA COMPOUNDS AND METHODS OF USE THEREOF

#2920

20110288147

2011-11-24

Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop

#2921

20110287084

2011-11-24

METHOD FOR REDUCING BODY FAT AND INCREASING LEAN BODY MASS BY REDUCING STEAROYL-COA DESATURASE 1 ACTIVITY

#2922

20110286997

2011-11-24

Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes

#2923

20110281313

2011-11-17

Production of acid and solvent in microorganisms

#2924

20110275697

2011-11-10

REGULATION OF CYCLIN D

#2925

20110275650

2011-11-10

Methods and compositions related to targeting monoacylglycerol lipase

#2926

20110274707

2011-11-10

Composition for improving inflammatory disease using ABH antigens

#2927

20110269951

2011-11-03

siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

#2928

20110269665

2011-11-03

COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY

#2929

20110263685

2011-10-27

Method for identification of sensitivity of a patient to telomerase inhibition therapy

#2930

20110263680

2011-10-27

Reduced size self-delivering RNAi compounds

#2931

20110263003

2011-10-27

Microbacterial peptide deformylase

#2932

20110262428

2011-10-27

TREATING CANCER BY MODULATING RNA HELICASES

#2933

20110257251

2011-10-20

TELOMERASE INHIBITORS AND METHODS OF USE THEREOF

#2934

20110257248

2011-10-20

RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis

#2935

20110256150

2011-10-20

Modulation of axon degeneration

#2936

20110251260

2011-10-13

NOVEL siRNAS AND METHODS OF USE THEREOF

#2937

20110251258

2011-10-13

RNAI CONSTRUCTS AND USES THEREOF

#2938

20110251255

2011-10-13

Methods and compositions for inhibiting the proliferation of cancer cells

#2939

20110251090

2011-10-13

PANCREATIC CANCER RELATED GENE TTLL4

#2940

20110250260

2011-10-13

INHIBITION OF BRAIN ENZYMES INOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION

#2941

20110250204

2011-10-13

Methods and compositions for diagnosing and treating diseases

#2942

20110245319

2011-10-06

RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders

#2943

20110244561

2011-10-06

SiRNA-mediated gene silencing

#2944

20110244059

2011-10-06

INHIBITING OBESITY PROGRESSION BY INHIBITING ADIPOCYTE DIFFERENTIATION WITH A PRE-ADIPOCYTE AUTOPHAGY INHIBITOR

#2945

20110243894

2011-10-06

METHODS OF TREATING HEPATITIS C VIRUS INFECTION

#2946

20110237649

2011-09-29

TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN 1

#2947

20110237648

2011-09-29

RNA interference in skin indications

#2948

20110237522

2011-09-29

Neutral nanotransporters

#2949

20110237501

2011-09-29

Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1

#2950

20110236956

2011-09-29

MULTICISTRONIC siRNA CONSTRUCTS TO INHIBIT TUMORS

#2951

20110236397

2011-09-29

LIMITED PROTEOLYSIS OF CD2AP AND PROGRESSION OF RENAL DISEASE

#2952

20110236394

2011-09-29

METHODS FOR THE REGULATION OF THE PROSTAGLANDIN F SYNTHASE (PGFS) ACTIVITY OF AKR1B1 AND USES THEREOF

#2953

20110230546

2011-09-22

dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION

#2954

20110230545

2011-09-22

EML4-ALK fusion gene

#2955

20110230542

2011-09-22

Compositions and methods for inhibiting expression of the PCSK9 gene

#2956

20110229984

2011-09-22

Materials and methods directed to asparagine synthetase and asparaginase therapies

#2957

20110229485

2011-09-22

INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA

#2958

20110224280

2011-09-15

Pharmaceutical Composition Comprising Anti PCSK9 Oligomers

#2959

20110223311

2011-09-15

Cottonseed oil and uses

#2960

20110218334

2011-09-08

PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS

#2961

20110213337

2011-09-01

Methods for the early diagnosis of ovarian cancer

#2962

20110213136

2011-09-01

ANTISENSE MODULATION OF STEAROYL-COA DESATURASE EXPRESSION

#2963

20110213016

2011-09-01

E2EPF Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof

#2964

20110212505

2011-09-01

BGL3 beta-glucosidase and nucleic acids encoding the same

#2965

20110207796

2011-08-25

ALPHA-SYNUCLEIN KINASE

#2966

20110207694

2011-08-25

MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM

#2967

20110206689

2011-08-25

Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof

#2968

20110201798

2011-08-18

Therapeutic compositions

#2969

20110201670

2011-08-18

Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases

#2970

20110196016

2011-08-11

Compositions and Methods for Inhibiting Expression of IKK2 Genes

#2971

20110190376

2011-08-04

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

#2972

20110189195

2011-08-04

Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase

#2973

20110184052

2011-07-28

ARGINASE II: A TARGET FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS

#2974

20110184046

2011-07-28

Compositions And Methods For Inhibiting Expression Of GSK-3 Genes

#2975

20110182917

2011-07-28

Method for treating fibromyalgia

#2976

20110178158

2011-07-21

Set of Antiangiogenic Molecules and Use Thereof

#2977

20110177571

2011-07-21

Designer calvin-cycle-channeled production of butanol and related higher alcohols

#2978

20110172287

2011-07-14

Compositions and methods for inhibiting tumor growth and metastasis

#2979

20110171730

2011-07-14

Conjugates For Use In Hepatocyte Free Uptake Assays

#2980

20110171184

2011-07-14

Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)

#2981

20110166201

2011-07-07

miRNAs as therapeutic targets in cancer

#2982

20110165227

2011-07-07

Compositions and methods using siRNA molecules for treatment of gliomas

#2983

20110160293

2011-06-30

PRMT1 for target genes of cancer therapy and diagnosis

#2984

20110160287

2011-06-30

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

#2985

20110160286

2011-06-30

Allele-specific RNA interference

#2986

20110160280

2011-06-30

CANCER-RELATED GENES, CDCA5, EPHA7, STK31 AND WDHD1

#2987

20110160277

2011-06-30

Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases

#2988

20110159010

2011-06-30

Compositions and methods for decreasing type III deiodinase activity to modulate adiposity and blood glucose levels

#2989

20110154520

2011-06-23

Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives

#2990

20110152355

2011-06-23

Method for predicting and detecting tumor metastasis

#2991

20110152348

2011-06-23

Methods for treating androgen receptor dependent disorders including cancers

#2992

20110151558

2011-06-23

METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS

#2993

20110151513

2011-06-23

SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA-1,6-FUCOSYLTRANSFERASE

#2994

20110150936

2011-06-23

ANTI-TUMORAL CELLS

#2995

20110150897

2011-06-23

INFLUENZA TARGETS

#2996

20110150832

2011-06-23

Furin-knockdown bi-functional RNA

#2997

20110145951

2011-06-16

TRANSGENIC SWEET SORGHUM WITH ALTERED LIGNIN COMPOSITION AND PROCESS OF PREPARATION THEREOF

#2998

20110144184

2011-06-16

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

#2999

20110143359

2011-06-16

Method for Identifying Drug-Sensitizing Antisense DNA Fragments and Use Thereof

#3000

20110142767

2011-06-16

RNAi-mediated inhibition of tumor necrosis factor α-related conditions